Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-03-06 @ 10:07 PM
Study NCT ID:
NCT01163903
Status:
COMPLETED
Last Update Posted:
2015-07-15
First Post:
2010-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours
Sponsor:
University Health Network, Toronto
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumours | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Advanced solid tumours | View |
| None | Pantoprazole | View |
| None | Doxorubicin | View |
| None | PANTO IV | View |
| None | Adriamycin | View |
| None | no standard treatment options | View |
| None | dose-escalation schedule | View |
| None | Phase I | View |
| None | single-centre | View |
| None | open label | View |
| None | dose finding | View |
| None | recommended phase II dose | View |
| None | proton pump inhibitor | View |
| None | advanced cancer | View |
| None | anthracycline | View |
| None | gastric acid secretion | View |